Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma
We present a case of recurrent pericardial effusion presenting during proton therapy in a 24-year-old female receiving mediastinal treatment for classical Hodgkin lymphoma. Pericardial effusion is typically considered an event accompanying lymphoma diagnosis or as a subacute or late effect of radiot...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Particle Therapy Co-operative Group
2021-10-01
|
| Series: | International Journal of Particle Therapy |
| Subjects: | |
| Online Access: | https://theijpt.org/doi/pdf/10.14338/IJPT-21-00010 |
| _version_ | 1797203739158773760 |
|---|---|
| author | Ashley Way, MD Savas Ozdemir, MD Barbara Berges, RN Nataliya Getman, MS Xiaoying Liang, PhD Nancy P. Mendenhall, MD Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil David Cutter, MRCP, FRCR, DPhil Raymond B. Mailhot Vega, MD, MPH |
| author_facet | Ashley Way, MD Savas Ozdemir, MD Barbara Berges, RN Nataliya Getman, MS Xiaoying Liang, PhD Nancy P. Mendenhall, MD Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil David Cutter, MRCP, FRCR, DPhil Raymond B. Mailhot Vega, MD, MPH |
| author_sort | Ashley Way, MD |
| collection | DOAJ |
| description | We present a case of recurrent pericardial effusion presenting during proton therapy in a 24-year-old female receiving mediastinal treatment for classical Hodgkin lymphoma. Pericardial effusion is typically considered an event accompanying lymphoma diagnosis or as a subacute or late effect of radiotherapy. Rarely has it been described as occurring during radiation treatment with photon-based radiotherapy, let alone proton therapy. It is unclear what underlying cause triggered recurrent effusion in this patient. Identifying and managing pericardial effusion during treatment delivery is important to consider as it may affect radiation dosimetry, particularly with proton therapy. Doing so will help ensure patients receive optimal treatment and minimize the risks of morbidity and mortality. |
| first_indexed | 2024-04-24T08:24:07Z |
| format | Article |
| id | doaj.art-d4df34c627c94d51a92719fb3b739ce5 |
| institution | Directory Open Access Journal |
| issn | 2331-5180 |
| language | English |
| last_indexed | 2024-04-24T08:24:07Z |
| publishDate | 2021-10-01 |
| publisher | Particle Therapy Co-operative Group |
| record_format | Article |
| series | International Journal of Particle Therapy |
| spelling | doaj.art-d4df34c627c94d51a92719fb3b739ce52024-04-16T23:33:42ZengParticle Therapy Co-operative GroupInternational Journal of Particle Therapy2331-51802021-10-0184768110.14338/IJPT-21-00010i2331-5180-8-4-76Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin LymphomaAshley Way, MD0Savas Ozdemir, MD1Barbara Berges, RN2Nataliya Getman, MS3Xiaoying Liang, PhD4Nancy P. Mendenhall, MD5Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil6David Cutter, MRCP, FRCR, DPhil7Raymond B. Mailhot Vega, MD, MPH81 Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USA2 Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, University of Florida College of Medicine, Jacksonville, FL, USA1 Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USA1 Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USA1 Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USA1 Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USA3 Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK4 Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK1 Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USAWe present a case of recurrent pericardial effusion presenting during proton therapy in a 24-year-old female receiving mediastinal treatment for classical Hodgkin lymphoma. Pericardial effusion is typically considered an event accompanying lymphoma diagnosis or as a subacute or late effect of radiotherapy. Rarely has it been described as occurring during radiation treatment with photon-based radiotherapy, let alone proton therapy. It is unclear what underlying cause triggered recurrent effusion in this patient. Identifying and managing pericardial effusion during treatment delivery is important to consider as it may affect radiation dosimetry, particularly with proton therapy. Doing so will help ensure patients receive optimal treatment and minimize the risks of morbidity and mortality.https://theijpt.org/doi/pdf/10.14338/IJPT-21-00010hodgkin lymphomaparticle therapyproton therapypericardial effusionradiotherapy |
| spellingShingle | Ashley Way, MD Savas Ozdemir, MD Barbara Berges, RN Nataliya Getman, MS Xiaoying Liang, PhD Nancy P. Mendenhall, MD Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil David Cutter, MRCP, FRCR, DPhil Raymond B. Mailhot Vega, MD, MPH Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma International Journal of Particle Therapy hodgkin lymphoma particle therapy proton therapy pericardial effusion radiotherapy |
| title | Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma |
| title_full | Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma |
| title_fullStr | Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma |
| title_full_unstemmed | Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma |
| title_short | Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma |
| title_sort | pericardial effusion during proton therapy in a patient with chemorefractory hodgkin lymphoma |
| topic | hodgkin lymphoma particle therapy proton therapy pericardial effusion radiotherapy |
| url | https://theijpt.org/doi/pdf/10.14338/IJPT-21-00010 |
| work_keys_str_mv | AT ashleywaymd pericardialeffusionduringprotontherapyinapatientwithchemorefractoryhodgkinlymphoma AT savasozdemirmd pericardialeffusionduringprotontherapyinapatientwithchemorefractoryhodgkinlymphoma AT barbarabergesrn pericardialeffusionduringprotontherapyinapatientwithchemorefractoryhodgkinlymphoma AT nataliyagetmanms pericardialeffusionduringprotontherapyinapatientwithchemorefractoryhodgkinlymphoma AT xiaoyingliangphd pericardialeffusionduringprotontherapyinapatientwithchemorefractoryhodgkinlymphoma AT nancypmendenhallmd pericardialeffusionduringprotontherapyinapatientwithchemorefractoryhodgkinlymphoma AT grahamcollinsmambbsmrcpfrcpathdphil pericardialeffusionduringprotontherapyinapatientwithchemorefractoryhodgkinlymphoma AT davidcuttermrcpfrcrdphil pericardialeffusionduringprotontherapyinapatientwithchemorefractoryhodgkinlymphoma AT raymondbmailhotvegamdmph pericardialeffusionduringprotontherapyinapatientwithchemorefractoryhodgkinlymphoma |